<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31185007</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1545-7885</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>PLoS biology</Title><ISOAbbreviation>PLoS Biol</ISOAbbreviation></Journal><ArticleTitle>A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses.</ArticleTitle><Pagination><StartPage>e3000281</StartPage><MedlinePgn>e3000281</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e3000281</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pbio.3000281</ELocationID><Abstract><AbstractText>Rhino- and enteroviruses are important human pathogens, against which no antivirals are available. The best-studied inhibitors are "capsid binders" that fit in a hydrophobic pocket of the viral capsid. Employing a new class of entero-/rhinovirus inhibitors and by means of cryo-electron microscopy (EM), followed by resistance selection and reverse genetics, we discovered a hitherto unknown druggable pocket that is formed by viral proteins VP1 and VP3 and that is conserved across entero-/rhinovirus species. We propose that these inhibitors stabilize a key region of the virion, thereby preventing the conformational expansion needed for viral RNA release. A medicinal chemistry effort resulted in the identification of analogues targeting this pocket with broad-spectrum activity against Coxsackieviruses B (CVBs) and compounds with activity against enteroviruses (EV) of groups C and D, and even rhinoviruses (RV). Our findings provide novel insights in the biology of the entry of entero-/rhinoviruses and open new avenues for the design of broad-spectrum antivirals against these pathogens.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdelnabi</LastName><ForeName>Rana</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9771-7312</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geraets</LastName><ForeName>James A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0003-3378-0683</Identifier><AffiliationInfo><Affiliation>Faculty of Biological and Environmental Sciences, Molecular and Integrative Bioscience Research Programme, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helsinki Institute of Life Sciences, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yipeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirabelli</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4785-5482</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flatt</LastName><ForeName>Justin W</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0001-5406-8156</Identifier><AffiliationInfo><Affiliation>Faculty of Biological and Environmental Sciences, Molecular and Integrative Bioscience Research Programme, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helsinki Institute of Life Sciences, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Domanska</LastName><ForeName>Au&#x161;ra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3772-6003</Identifier><AffiliationInfo><Affiliation>Faculty of Biological and Environmental Sciences, Molecular and Integrative Bioscience Research Programme, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helsinki Institute of Life Sciences, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delang</LastName><ForeName>Leen</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8874-675X</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jochmans</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9265-6028</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Timiri Ajay</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences &amp; Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayaprakash</LastName><ForeName>Venkatesan</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-9724-4153</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences &amp; Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>Barij Nayan</ForeName><Initials>BN</Initials><Identifier Source="ORCID">0000-0002-6558-3572</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences &amp; Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leyssen</LastName><ForeName>Pieter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7537-1688</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butcher</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0001-7060-5871</Identifier><AffiliationInfo><Affiliation>Faculty of Biological and Environmental Sciences, Molecular and Integrative Bioscience Research Programme, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helsinki Institute of Life Sciences, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neyts</LastName><ForeName>Johan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0033-7514</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Biol</MedlineTA><NlmUniqueID>101183755</NlmUniqueID><ISSNLinking>1544-9173</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074995">viral protein 1, rhinovirus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="Y">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020285" MajorTopicYN="N">Cryoelectron Microscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076722" MajorTopicYN="N">Drug Development</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008968" MajorTopicYN="N">Molecular Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31185007</ArticleId><ArticleId IdType="pmc">PMC6559632</ArticleId><ArticleId IdType="doi">10.1371/journal.pbio.3000281</ArticleId><ArticleId IdType="pii">PBIOLOGY-D-18-01199</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mirabelli C, Scheers E, Neyts J. Novel therapeutic approaches to simultaneously target rhinovirus infection and asthma/COPD pathogenesis. F1000Research. 2017;6: 1860 10.12688/f1000research.11978.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.11978.1</ArticleId><ArticleId IdType="pmc">PMC5657016</ArticleId><ArticleId IdType="pubmed">29123648</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Kuppeveld FJM Van. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol. Springer US; 2018; 10.1038/s41579-018-0005-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E-J, Shin Y-J, Kim J-H, Kim T-G, Chang S-Y. Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res. 2017;6: 4 10.7774/cevr.2017.6.1.4</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm-Hansen CC, Midgley SE, Fischer TK. Global emergence of enterovirus D68: A systematic review. The Lancet Infectious Diseases. 2016. pp. e64&#x2013;e75. 10.1016/S1473-3099(15)00543-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00543-5</ArticleId><ArticleId IdType="pubmed">26929196</ArticleId></ArticleIdList></Reference><Reference><Citation>Aylward B, Tangermann R. The global polio eradication initiative: Lessons learned and prospects for success. Vaccine. 2011;29 10.1016/j.vaccine.2011.10.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.10.068</ArticleId><ArticleId IdType="pubmed">22486981</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TJ, Kremer MJ, Luo M, Vriend G, Arnold E, Kamer G, et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science. 1986;233: 1286&#x2013;1293. 10.1126/science.3018924</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3018924</ArticleId><ArticleId IdType="pubmed">3018924</ArticleId></ArticleIdList></Reference><Reference><Citation>Collett MS, Hincks JR, Benschop K, Duizer E, van der Avoort H, Rhoden E, et al. Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model. J Infect Dis. 2017;215: 335&#x2013;343. 10.1093/infdis/jiw542</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw542</ArticleId><ArticleId IdType="pmc">PMC5393058</ArticleId><ArticleId IdType="pubmed">27932608</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijsma A, Franco D, Tucker S, Hilgenfeld R, Froeyen M, Leyssen P, et al. The capsid binder vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication. Antimicrob Agents Chemother. 2014;58: 6990&#x2013;6992. 10.1128/AAC.03328-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.03328-14</ArticleId><ArticleId IdType="pmc">PMC4249361</ArticleId><ArticleId IdType="pubmed">25199773</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Hill MG, Klose T, Chen Z, Watters K, Bochkov YA, et al. Atomic structure of a rhinovirus C, a virus species linked to severe childhood asthma. Proc Natl Acad Sci. 2016;113: 8997&#x2013;9002. 10.1073/pnas.1606595113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1606595113</ArticleId><ArticleId IdType="pmc">PMC4987780</ArticleId><ArticleId IdType="pubmed">27511920</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear DC, Tull TM, Seipel ME, Groarke JM. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother. 1999;43: 2109&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89431</ArticleId><ArticleId IdType="pubmed">10471549</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelnabi R, Morais ATS de, Leyssen P, Imbert I, Beaucourt S, Blanc H, et al. Understanding the mechanism of the broad-spectrum antiviral activity of favipiravir (T-705): Key role of the F1 motif of the viral polymerase. J Virol. 2017;91: e00487&#x2013;17. 10.1128/JVI.00487-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00487-17</ArticleId><ArticleId IdType="pmc">PMC5446660</ArticleId><ArticleId IdType="pubmed">28381577</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix C, Laconi S, Angius F, Coluccia A, Silvestri R, Pompei R, et al. In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses. Virol J. Virology Journal; 2015;12: 106 10.1186/s12985-015-0330-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0330-4</ArticleId><ArticleId IdType="pmc">PMC4501209</ArticleId><ArticleId IdType="pubmed">26169596</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijsma A, Thibaut HJ, Spieser S a H, De Palma A, Koukni M, Rhoden E, et al. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1. Antiviral Res. Elsevier B.V.; 2014;110: 1&#x2013;9. 10.1016/j.antiviral.2014.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.07.003</ArticleId><ArticleId IdType="pubmed">25043639</ArticleId></ArticleIdList></Reference><Reference><Citation>Muckelbauer JK, Kremer M, Minor I, Tong L, Zlotnick A, Johnson JE, et al. Structure determination of coxsackievirus B3 to 3.5 &#xc5; resolution. Acta Crystallogr Sect D Biol Crystallogr. 1995;51: 871&#x2013;887. 10.1107/S0907444995002253</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444995002253</ArticleId><ArticleId IdType="pubmed">15299757</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaut HJ, van der Linden L, Jiang P, Thys B, Canela MD, Aguado L, et al. Binding of glutathione to enterovirus capsids is essential for virion morphogenesis. PLoS Pathog. 2014;10(4). 10.1371/journal.ppat.1004039</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004039</ArticleId><ArticleId IdType="pmc">PMC3983060</ArticleId><ArticleId IdType="pubmed">24722756</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Chipman PR, Howitt J, Bator CM, Whitt MA, Baker TS, et al. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol. 2001;8: 874&#x2013;878. 10.1038/nsb1001-874</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsb1001-874</ArticleId><ArticleId IdType="pmc">PMC4152846</ArticleId><ArticleId IdType="pubmed">11573093</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoder JD1, Cifuente JO, Pan J, Bergelson JM HS. The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface. J Virol. 2012;86: 12571&#x2013;81. 10.1128/JVI.01592-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01592-12</ArticleId><ArticleId IdType="pmc">PMC3497627</ArticleId><ArticleId IdType="pubmed">22973031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Shingler KL, Organtini LJ, Ashley RE, Makhov AM, Conway JF, et al. The novel asymmetric entry intermediate of a picornavirus captured with nanodiscs. Sci Adv. 2016;2 10.1126/sciadv.1501929</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1501929</ArticleId><ArticleId IdType="pmc">PMC4996645</ArticleId><ArticleId IdType="pubmed">27574701</ArticleId></ArticleIdList></Reference><Reference><Citation>Timiri AK, Selvarasu S, Kesherwani M, Vijayan V, Sinha BN, Devadasan V, et al. Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors. Bioorg Chem. 2015;62: 74&#x2013;82. 10.1016/j.bioorg.2015.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioorg.2015.07.005</ArticleId><ArticleId IdType="pubmed">26247308</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27: 493&#x2013;497. 10.1016/j.jvs.2011.05.096</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2011.05.096</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma AM, Thibaut HJ, Van Der Linden L, Lanke K, Heggermont W, Ireland S, et al. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. Antimicrob Agents Chemother. 2009;53: 1850&#x2013;1857. 10.1128/AAC.00934-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00934-08</ArticleId><ArticleId IdType="pmc">PMC2681499</ArticleId><ArticleId IdType="pubmed">19237651</ArticleId></ArticleIdList></Reference><Reference><Citation>Timiri AK, Basha BH, Abdelabi R, Neyts Y, Leyssen P, Sinha BN J V. In silico development of a novel putative inhibitor of the 3C protease of Coxsackievirus B3 with a benzene sulfonamide skeleton. J Pharm Chem. 2017;4(3): 25&#x2013;34.</Citation></Reference><Reference><Citation>Mapoles JE, Krah DL, Crowell RL. Purification of a HeLa cell receptor protein for group B coxsackieviruses. J Virol. 1985;55: 560&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC255009</ArticleId><ArticleId IdType="pubmed">2991580</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng SQ, Palovcak E, Armache JP, Verba KA, Cheng Y, Agard DA. MotionCor2: Anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nature Methods. 2017. pp. 331&#x2013;332. 10.1038/nmeth.4193</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4193</ArticleId><ArticleId IdType="pmc">PMC5494038</ArticleId><ArticleId IdType="pubmed">28250466</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K. Gctf: Real-time CTF determination and correction. J Struct Biol. 2016;193: 1&#x2013;12. 10.1016/j.jsb.2015.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.11.003</ArticleId><ArticleId IdType="pmc">PMC4711343</ArticleId><ArticleId IdType="pubmed">26592709</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheres SHW. Semi-automated selection of cryo-EM particles in RELION-1.3. J Struct Biol. 2015;189: 114&#x2013;122. 10.1016/j.jsb.2014.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2014.11.010</ArticleId><ArticleId IdType="pmc">PMC4318617</ArticleId><ArticleId IdType="pubmed">25486611</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera&#x2014;A Visualization System for Exploratory Research and Analysis. J Comput Chem. 2004;25: 1605&#x2013;1612. 10.1002/jcc.20084</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20084</ArticleId><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheres SHW. RELION: Implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol. 2012;180: 519&#x2013;530. 10.1016/j.jsb.2012.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2012.09.006</ArticleId><ArticleId IdType="pmc">PMC3690530</ArticleId><ArticleId IdType="pubmed">23000701</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal PB, Crowther RA, Henderson R. An Objective Criterion for Resolution Assessment in Single-particle Electron Microscopy (appendix). J Mol Biol. 2003;333: 743&#x2013;745.</Citation></Reference><Reference><Citation>Roy A, Kucukural A, Zhang Y. I-TASSER: A unified platform for automated protein structure and function prediction. Nat Protoc. 2010;5: 725&#x2013;738. 10.1038/nprot.2010.5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2010.5</ArticleId><ArticleId IdType="pmc">PMC2849174</ArticleId><ArticleId IdType="pubmed">20360767</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Cowtan K. Coot: Model-building tools for molecular graphics. Acta Crystallogr Sect D Biol Crystallogr. 2004;60: 2126&#x2013;2132. 10.1107/S0907444904019158</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444904019158</ArticleId><ArticleId IdType="pubmed">15572765</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabuco LG, Villa E, Mitra K, Frank J, Schulten K. Flexible Fitting of Atomic Structures into Electron Microscopy Maps Using Molecular Dynamics. Structure. 2008;16: 673&#x2013;683. 10.1016/j.str.2008.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2008.03.005</ArticleId><ArticleId IdType="pmc">PMC2430731</ArticleId><ArticleId IdType="pubmed">18462672</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, et al. Scalable molecular dynamics with NAMD. Journal of Computational Chemistry. 2005. pp. 1781&#x2013;1802. 10.1002/jcc.20289</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20289</ArticleId><ArticleId IdType="pmc">PMC2486339</ArticleId><ArticleId IdType="pubmed">16222654</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. J Mol Graph. 1996;14: 33&#x2013;38. 10.1016/0263-7855(96)00018-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0263-7855(96)00018-5</ArticleId><ArticleId IdType="pubmed">8744570</ArticleId></ArticleIdList></Reference><Reference><Citation>Krissinel E, Henrick K. Inference of Macromolecular Assemblies from Crystalline State. J Mol Biol. 2007;372: 774&#x2013;797. 10.1016/j.jmb.2007.05.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.05.022</ArticleId><ArticleId IdType="pubmed">17681537</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>